Old Web
English
Sign In
Acemap
>
Paper
>
Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.
Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.
2017
Edwin J. Velazquez
Kiara Vaden
Michelle H. Townsend
Evita G. Weagel
Scott Weber
Richard A. Robison
Kim L. O'Neill
Keywords:
Chimeric antigen receptor
Immunotherapy
Cancer
Virology
Thymidine kinase 1
Biology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]